|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-2-15
|
|
pubmed:abstractText |
To determine in a multicentre, multivendor trial the diagnostic performance for perfusion-cardiac magnetic resonance (perfusion-CMR) in comparison with coronary X-ray angiography (CXA) and single-photon emission computed tomography (SPECT).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
pubmed-author:AhlstromHakanH,
pubmed-author:Al-SaadiNidalN,
pubmed-author:DillThorstenT,
pubmed-author:FlammScott DSD,
pubmed-author:JohanssonLarsL,
pubmed-author:LarssonHenrik B WHB,
pubmed-author:LombardiMassimoM,
pubmed-author:MarquardtMoritzM,
pubmed-author:SchwitterJuergJ,
pubmed-author:WackerChristian MCM,
pubmed-author:van RossumAlbert CAC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
480-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18208849-Adult,
pubmed-meshheading:18208849-Aged,
pubmed-meshheading:18208849-Aged, 80 and over,
pubmed-meshheading:18208849-Coronary Artery Disease,
pubmed-meshheading:18208849-Epidemiologic Methods,
pubmed-meshheading:18208849-Female,
pubmed-meshheading:18208849-Humans,
pubmed-meshheading:18208849-Magnetic Resonance Angiography,
pubmed-meshheading:18208849-Male,
pubmed-meshheading:18208849-Middle Aged,
pubmed-meshheading:18208849-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial.
|
|
pubmed:affiliation |
Division of Cardiology, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. juerg.schwitter@usz.ch
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
